Combination treatment of low dose Anti-Thymocyte Globulin (ATG), Rituximab and high dose Sirolimus as induction agents in immune-conditioned recipients

International Immunopharmacology

Volumn 6, Issue 13-14, 2006, Pages 1973-1976

  Ravichandran, Palani ^a   Natrajan, T ^a   Jaganathan, R ^a  

^a St Thomas Hospital   (India)

Author keywords

ATG; Immunosuppression; Induction therapy; Rituximab; Transplantation

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ARTICLE; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DOUBLE FILTRATION PLASMAPHERESIS; FEMALE; GRAFT FAILURE; HEMOLYTIC UREMIC SYNDROME; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LOW DRUG DOSE; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLEEN RADIATION; TREATMENT OUTCOME; URINE INCONTINENCE; WOUND HEALING IMPAIRMENT;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SIROLIMUS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 33845217279     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.09.013     Document Type: Article

References (13)

1. Knechtle S.J., Pirsch J.D., Fechner Jr. J.H., Becker B.N., Friedl A., Colvin R.B., et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 3 6 (June 2003) 722
2. Ravichandran P., Nataraj T., and Jaganathan R. Splenic radiation and double filtration plasmapheresis in cross match positive live renal transplantation. Transplant Proc 37 (2005) 1806-1807
3. Hoshinaga K., Aikawa A., Murai M., Yamamoto H., Hirayama N., Shishido S., et al. Regimen of tacrolimus-based immunosuppression with basiliximab, mycophenolate mofetil, and low-dose steroid reduces acute rejection in kidney transplants. Transplant Proc 37 (2005) 1762-1763
4. El-Sabrout R., Delaney V., Butt F., Qadir M., Hanson P., Tuteja S., et al. Improved freedom from rejection after a loading dose of sirolimus. Transplantation 75 1 (2003) 86-90
5. Civati G., Minetti E., Busnach G., Perego A., Brando B., Broggi M.L., et al. Low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: a retrospective analysis comparing two ATGs. Transplant Proc 30 (1998) 1343-1345
6. Vieira C.A., Agarwal A., Book B.K., Sidner R.A., Bearden C.M., Gebel H.M., et al. Rituximab for reduction of anti-HLA antibodies in patients awaiting renal trasnplantation: safety, pharmacodynamics and pharmacokinetics. Transplantation 77 4 (Feb 27 2004) 542-548
7. Sawada T., Fuchinoue S., Kawase T., Kubota K., and Teraoka S. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatable kidney trasnplantation. Clin Transplant 18 3 (Jun 2004) 254-260
8. Garrett H.E., Groshart K., Duvall-seaman D., Combs D., and Suggs R. Treatment of humoral rejection with rituximab. Ann Thorac Surg 74 4 (2002) 1240-1242
9. Gratwohl A., Hermans J., Biezen A.V., Arcese W., Debusscher L., Ernst P., et al. Splenic radiation before bone marrow transplantation for chronic myeloid leukemia. Br J Hematol 95 (1996) 494
10. Chapman J.R. Optimizing the long term outcome of renal transplants: opportunities created by sirolimus. Transplant Proc 35 Suppl3A (2003) 67S-72S
11. Stegall M.D., Larson T.S., Prieto M., Gloor J., Textor S., Nyberg S., et al. Kidney transplantation without Calcineurin inhibitors using sirolimus. Transplant Proc 35 Suppl 3A (2003) 125S-127S
12. Citterio F., Scata M.C., Violi P., Romagnoli J., Pozzetto U., Nanni G., et al. Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients. Transplant Proc 35 (2003) 1292-1294
13. Johny K.V., Nampoory M.R.N., Hamid M.H., Nair M.P., Smahan M., and Al-Moussawi M. Low-dose sirolimus in combination with mycophenolate in calcineurin inhibitor elimination: the Kuwaiti experience. Transplant Proc 35 (2003) 2750-2751